Skip to main content


Simon Says “Don’t Do This” (1.27.2023)

Dr. Jack Cush reviews this weeks journal articles, focuses on studies that should not have been done and responds to viewer questions in Ask Cush Anything

The RheuNow Podcast Preview - Til Death Do Us Part (1.20.2023)

Dr. Jack Cush reviews the highlights from the past week on

Rheum Believe It Or Not (1.13.2023)

Dr. Jack Cush reviews the notable standouts in the news since the 1st of January. Surprising reports on ferritin, alcohol benefits, cannabis for pain and a lower dementia risk with hydroxychloroquine.

RheumNow Podcast- 2022 Rheumatology Year in Review

Dr. Jack Cush Reviews the highlight from 2022 in Rheumatology Check out the full podcast at

Fever, FROST, & Pericarditis (12.16.2022)

Dr. Jack Frost reviews the news and journal reports with a bonus audience question at the end.

Biosimilar Bonanza In 2023 (12.9.2022)

Dr. Jack Cush reviews the news and journal articles from this past week on

Rheum Manpower Needs - More Programs! (12.2.2022)

Dr. Jack Cush reviews the news and journal articles from the past week on

Biologics in Lupus – Why, Who, and When? Sponsored by GSK US Medical Affairs

Leading experts from the SLE Educators’ Network discuss how biologic therapies may help address key unmet needs in lupus, while highlighting how clinicians can identify the most appropriate patients for biologic treatment.

Topic Podcasts - JAK TYK2

ACR22 Year in Review Report Deucravacitinib in PsA JAK inhibitors in rheumatic diseases JAK vs TNF inhibitor Infections in RA New Treatments for SLE? Prelude to a Meeting (ACR22) (11.11.2022) Switching Between JAK Inhibiters in RA Tapering Methotrexate with Biologics or JAK Inhibitors in RA Tofacitinib and RA-ILD Upadacitinib vs Adalimumab in PsA u

Topic Podcasts - Lupus Part3

Addressing Sexual Health and STD Prevention in Lupus Patients CAR-T Therapies in Antiphospholipid Antibody Syndrome Copays Reduce Adherence to SLE Medications Diffuse alveolar hemorrhage in antiphospholipid syndrome Hydroxychloroquine Update from ACR22 Low-grade Proteinuria in Non Renal Lupus: Should We be Worried? Photovoice: A New Visual Research

Topic Podcasts - Lupus Part2

ACR22 Daily Recap: Saturday Recap New Treatments for SLE?

Topic Podcasts - Lupus Part1

A Novel Treatment Response Measurement Tool for Lupus ACR22 Year in Review Report Breakthrough COVID infection in SLE during Omicron era Effect of voclosporin in class V lupus nephritis Lupus, Sex and STDs Poor Medication Adherence in SLE and How to Improve It Prelude to a Meeting (ACR22) (11.11.2022) Should You Repeat the ENA Panel? Urinary Biomar